Safety and Necessity of Antiplatelet Therapy on Patients Underwent Endovascular Aortic Repair with Both Stanford Type B Aortic Dissection and Coronary Heart Disease
查看参考文献17篇
|
文摘
|
Background: Acute aortic dissection is known as the most dangerous aortic disease, with management and prognosis determined as the disruption of the medial layer provoked by intramural bleeding. The objective of this study was to evaluate the safety and necessity of antiplatelet therapy on patients with Stanford Type B aortic dissection (TBAD) who underwent endovascular aortic repair (EVAR). Methods: The present study retrospectively analyzed 388 patients with TBAD who underwent EVAR and coronary angiography. The primary outcomes were hemorrhage, death, endoleak,recurrent dissection,myocardial infarction, and cerebral infarction in patients with and without aspirin antiplatelet therapy at 1 month and 12 months. Results: Of those 388 patients, 139 (35.8%) patients were treated with aspirin and 249 (64.2%) patients were not treated with aspirin. Patients in the aspirin group were elderly (57.0±10.3 years vs.52.5±11.9 years, respectively,x~2 = 3.812,P < 0.001) and had more hypertension (92.1% vs.83.9%, respectively,x~2 = 5.191,P=0.023) and diabetes (7.2% vs.2.8%, respectively,x~2 = 4.090,P=0.043) than in the no-aspirin group. Twelve patients (aspirin group vs. no-aspirin group; 3.6% vs.2.8%, respectively, x~2 = 0.184,P=0.668) died at 1-month follow-up, while the number was 18 (4.6% vs.5.0%, respectively, x~2 = 0.027,P = 0.870) at 12-month follow-up. Hemorrhage occurred in 1 patient (Bleeding Academic Research Consortium [BARC] Type 2) of the aspirin group, and 3 patients (1 BARC Type 2 and 2 BARC Type 5) in the no-aspirin group at 1-month follow-up (x~2 = 0.005, P = 0.944). New hemorrhage occurred in five patients in the no-aspirin group at 12-month follow-up. Three patients in the aspirin group while five patients in the no-aspirin group had recurrent dissection for endoleak at 1-month follow-up (2.3% vs.2.2%, respectively, x~2 = 0.074,P = 0.816). Four patients had new dissection in the no-aspirin group at 12-month follow-up (2.3% vs.3.8%, respectively,x~2 = 0.194,P=0.660). Each group had one patient with myocardial infarction at 1-month follow-up (0.8% vs.0.4%, respectively,x~2 = 0.102,P=0.749) and one more patient in the no-aspirin group at 12-month follow-up. No one had cerebral infarction in both groups during the 12-month follow-up. In the percutaneous coronary intervention (PCI) subgroup, 44 (31.7%) patients had taken dual-antiplatelet therapy (DAPT,aspirin + clopidogrel) and the other 95 (68.3%) patients had taken only aspirin. There was no significant difference in hemorrhage (0% vs.1.1%, respectively, x~2 = 0.144, P = 0.704),death (4.8% vs.4.5%, respectively,x~2 = 0.154,P=0.695),myocardial infarction (2.4% vs.0%,respectively, x~2 = 0.144, P = 0.704),endoleak,and recurrent dissection (0% vs.3.4%, respectively,x~2 = 0.344,P = 0.558) between the two groups at 12-month follow-up, Conclusions: The present study indicated that long-term oral low-dose aspirin was safe for patients with both TBAD and coronary heart disease who underwent EVAR. For the patients who underwent both EVAR and PCI, DAPT also showed no increase in hemorrhage, endoleak, recurrent dissection,death, and myocardial infarction. |
|
来源
|
Chinese Medical Journal
,2017,130(19):2321-2325 【核心库】
|
|
DOI
|
10.4103/0366-6999.215330
|
|
关键词
|
Acute Coronary Syndrome
;
Antiplatelet
;
Aortic Dissection
;
Endovascular Aortic Repair
|
|
地址
|
Department of Cardiology, General Hospital of Shenyang Military Region, Liaoning, Shenyang, 110016
|
|
语种
|
英文 |
|
文献类型
|
研究性论文 |
|
ISSN
|
0366-6999 |
|
学科
|
医药、卫生 |
|
文献收藏号
|
CSCD:6083607
|
参考文献 共
17
共1页
|
|
1.
Clouse W D. Acute aortic dissection: Population-based incidence compared with degenerative aortic aneurysm rupture.
Mayo Clin Proc,2004,79:176-180
|
被引
22
次
|
|
|
|
|
2.
White A. Acute aortic emergencies-Part 2: Aortic dissections.
Adv Emerg Nurs J,2013,35:28-52
|
被引
3
次
|
|
|
|
|
3.
Safi H J. Aortic dissection.
Br J Surg,2004,91:523-525
|
被引
3
次
|
|
|
|
|
4.
Hiratzka L F. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists,Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine.
J Am Coll Cardiol,2010,55:e27-e129
|
被引
61
次
|
|
|
|
|
5.
Jing Q. Percutaneous transluminal intervention and antiplatelet therapy following endovascular graft exclusion for Stanford B thoracic aortic dissection.
Int J Cardiol,2013,165:478-482
|
被引
2
次
|
|
|
|
|
6.
Davis D P. The inadvertent administration of anticoagulants to ED patients ultimately diagnosed with thoracic aortic dissection.
Am J Emerg Med,2005,23:439-442
|
被引
1
次
|
|
|
|
|
7.
De Rango P. Safety of chronic anticoagulation therapy after endovascular abdominal aneurysm repair (EVAR).
Eur J Vase Endovasc Surg,2014,47:296-303
|
被引
1
次
|
|
|
|
|
8.
Cambria R P. Vascular complications associated with spontaneous aortic dissection.
J Vase Surg,1988,7:199-209
|
被引
15
次
|
|
|
|
|
9.
Fann J I. Treatment of patients with aortic dissection presenting with peripheral vascular complications.
Ann Surg,1990,212:705-713
|
被引
10
次
|
|
|
|
|
10.
Pecoraro F. Early endovascular aneurysm repair after percutaneous coronary interventions.
J Vase Surg,2015,61:1146-1150
|
被引
2
次
|
|
|
|
|
11.
Erbel R. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC).
Eur Heart J,2014,35:2873-2926
|
被引
200
次
|
|
|
|
|
12.
Guo B L. Effect of Intravascular Ultrasound-assisted Thoracic Endovascular Aortic Repair for "Complicated" Type B Aortic Dissection.
Chin Med J,2015,128:2322-2329
|
被引
1
次
|
|
|
|
|
13.
Huang W H. Perioperative aortic dissection rupture after endovascular stent graft placement for treatment of type B dissection.
Chin Med J,2013,126:1636-1641
|
被引
3
次
|
|
|
|
|
14.
Bayazit M. Routine coronary arteriography before abdominal aortic aneurysm repair.
Am J Surg,1995,170:246-250
|
被引
2
次
|
|
|
|
|
15.
Paravastu S C. Endovascular repair of abdominal aortic aneurysm.
Cochrane Database Syst Rev,2014,1:CD004178
|
被引
5
次
|
|
|
|
|
16.
Rose J. Comparative safety of endovascular aortic aneurysm repair over open repair using patient safety indicators during adoption.
JAMA Surg,2014,149:926-932
|
被引
1
次
|
|
|
|
|
17.
Scanlon P J. ACC/AHA guidelines for coronary angiography: Executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions.
Circulation,1999,99:2345-2357
|
被引
12
次
|
|
|
|
|
了解气象卫星更多信息，请访问